<p>On this weeks podcast we catch up with Emilie Gross at 
BioSymetrics who is on the leading edge of Artificial Intelligence and Drug Discovery. </p>

On this weeks podcast we catch up with Emilie Gross at BioSymetrics who is on the leading edge of Artificial Intelligence and Drug Discovery.

Emilie Gross PhD, MBA - Artificial Intelligence and Drug Discovery

Access insights from thought leaders, CEOs and entrepreneurs in the life sciences ecosystem on the Innovation Wave podcast. On the show we dive into topics relevant to today’s quickly changing Life Sciences industry, including capital financing, partnering, mergers &amp; acquisitions, real estate, and growth strategies. 

Host David Crean, Life Science investor and connector, and Bob McGriff, corporate real estate expert are fully immersed in the Life Science Ecosystem and have candid, real life conversations with guests who are on the leading edge of the industry.

Business

Access insights from thought leaders, CEOs and entrepreneurs in the life sciences ecosystem on the Innovation Wave podcast. On the show we dive into topics relevant to today’s quickly changing Life Sciences industry, including capital financing, partnering, mergers & acquisitions, real estate, and growth strategies. Host David Crean, Life Science investor and connector, and Bob McGriff, corporate real estate expert are fully immersed in the Life Science Ecosystem and have candid, real life conversations with guests who are on the leading edge of the industry.

Share Emilie Gross PhD, MBA - Artificial Intelligence and Drug Discovery

Sign up to save your podcasts

Emilie Gross PhD, MBA - Artificial Intelligence and Drug Discovery

Emilie Gross PhD, MBA - Artificial Intelligence and Drug Discovery